跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Retasar - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Retasar
Approved
STANDARD
Retasar
Emil Pharmaceutical Industries Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
4115a650a8852ec2
Company
Emil Pharmaceutical Industries Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
4115a650a8852ec2
Drug Approval Philippines Name
Retasar
Product Name
Retasar
Registration Number
DRP-10067-01
Brand Name
Retasar
Generic Name
Losartan Potassium
Dosage Form
Film-Coated Tablet
Dosage Strength
100 mg
Manufacturer
Emil Pharmaceutical Industries Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Reta Drug
Issuance Date
23 September 2024
Expiry Date
26 May 2028
Pharmacologic Category
Angiotensin II Receptor Blocker
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
4115a650a8852ec2
Type
Standard
Back to Philippines FDA Approvals